Categories: Top News

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of One Point Patient Care Customers Whose Data May Have Been Compromised

NEWTOWN, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) — The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by One Point Patient Care (“OPPC”). OPPC learned of suspicious activity on or about August 8, 2024. To join this case, go HERE.

About One Point Patient Care

One Point Patient Care, headquartered in Tempe, Arizona, is a hospice pharmacy providing services to over 40,000 patients daily across various service platforms.

What happened?

On or about August 8, 2024, OPPC detected unauthorized activity on its network. After an investigation, it was discovered that some individual’s personal information was obtained during the incident. This personal information may have included names, residence information, medical records, diagnosis, prescription details, and Social Security numbers. Up to 800,000 people have been affected by this data breach.

How can I protect my personal data?

If you receive a data breach notification, you must guard against possible misuse of your personal information, including identity theft and fraud, by regularly reviewing your account statements and monitoring your credit reports for suspicious or unauthorized activity. Additionally, you should consider legal options for mitigating such risks.

Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies for customers who may have had their sensitive personal and patient data compromised by the OPPC data breach.

For more information, please contact:

Marc H. Edelson, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492
Email: medelson@edelson-law.com
Web: www.edelson-law.com

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.

This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so counsel does not represent you unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing now. Your ability to share in any potential future recovery does not depend on serving as lead plaintiff.

GlobeNewswire

GlobeNewswire, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Recent Posts

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZYXI

NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights…

8 hours ago

Writer/painter-turned cultural heritage preserver behind Spring Festival’s UNESCO heritage status success

Global Times: Feng Jicai leads efforts to preserve China's cultural heritage through art, literature, and…

8 hours ago

Boston Hemp Launches New Line of Premium THCa Concentrates

Hanover, MA , April 20, 2025 (GLOBE NEWSWIRE) -- Boston Hemp Inc., a leader in…

9 hours ago

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Bakkt Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BKKT

NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights…

9 hours ago

Australian Dollar Speculative Net Positions Improve, But Remain in the Negative

The latest data release from the Commodity Futures Trading Commission (CFTC) reveals a marginal improvement…

16 hours ago

This website uses cookies.